The Pineal Gland, a small structure lying in the very center of the
brain, is rather peculiar since its precise function has never been
fully understood. It has a role in the production of "Melatonin",
a hormone, the lack of which has been associated with "jet-lag".
While rare, Pineal Gland Tumors and Pineal Region Tumors account
for less than 1.5% of all human brain tumors. The symptoms caused
by these tumors, result from tumor invasion or compression of the
various nearby anatomical structures and are influenced by the
different pathological entities that comprise the group called
"Pineal Region Tumors".
Among the symptoms produced by these tumors, the most common are
related to local pressure. Because of its critical, central,
anatomical location, these tumors can obstruct normal Cerebrospinal
Fluid (CSF) pathways by compressing the Cerebral Aqueduct (or
Aqueduct of Sylvius), a small channel connecting the Third to the
Fourth Ventricle. This results in a condition known as
"hydrocephalus" ("water on the brain"). Since CSF is constantly
being produced, any obstruction to its flow pattern or rate of
reabsorbtion will result in a "ballooning" of the ventricular
system and increased intracranial pressure. This is manifested by
headaches, vomiting, lethargy and altered mental status.
Compression of the adjacent brain structure the Superior
Colliculus causes visual disturbance, the most common of which
is Parinaud's Syndrome (inability to look upward, double vision
and nystagmus - a flickering of the eyes back and forth). Direct
invasion of the Thalamus can cause loss of sensation to half the
body, weakness of half the body, and intermittent pain. Invasion
of the vital centers of the Hypothalamus can cause disturbances
in body temperature and water regulation, sleepiness, and weight
gain. Other symptoms include memory problems, poor coordination
and tremors.
The diagnosis of a Pineal Region Tumor is best established by MRI
scanning since it has better resolution compared to CT scan.
There are certain helpful additional investigations that can be
done once a Pineal Region Tumor is identified. Blood tests for
"tumor markers" can be used to identify certain types of tumors.
The most useful and specific markers for Pineal Region Tumors are
beta human chorionic gonadotropin (ß-HCG) and the alpha-fetoprotein
(AFP). ß-HCG is produced by Choriocarcinoma and Geminomas and can
be detected in the blood and cerebrospinal fluid. Elevated AFP
suggests a malignant germ cell tumor, most often Endodermal Sinus
Tumor. Elevation of both markers can be found in Embryonal Cell
Carcinomas, Malignant Teratomas, or Mixed Germ Cell Tumors.
Pineal Parenchymal Tumors (Pineoblastoma and Pineocytoma)
Tumors of the Pineal Parenchymal Cells are the second largest group
of Pineal Region Tumors, accounting for 30% of all tumors in this
location. There are two types of tumors in this group, Pineoblastoma
and Pineocytoma, differing only by their histological appearance,
level of differentiation and degree of malignancy.
Germ Cell Tumors (Pure Germinoma, Embryonal Cell Carcinoma,
Endodermal Sinus Tumor, Choriocarcinoma, Immature Teratoma and
Mature Teratoma)
Germ Cell Tumors account for more than half of all Pineal Region
Tumors. Pure Germinomas account for 65% of all intracranial Germ
Cell Tumors. Germinomas are poorly circumscribed and often seed
the ventricular system. The Embryonal Cell Carcinoma, the least
frequently reported intracranial Germ Cell Tumor, is usually highly
malignant as are the rare and highly invasive Endodermal Sinus
Tumors. Teratomas can be either immature or mature and represent
the expression of embryonic differentiation in germ cell tumors.
These well circumscribed tumors are usually round or lobulated
and multicystic. They produce symptoms by compressing the
surrounding structures.
Tumors of Supportive Tissues & Adjacent Structures
(Astrocytomas, Ependymomas, Meningiomas, Hemangiopericytomas)
Each of these tumors produce symptoms related to their size (mass)
by compressing surrounding anatomical structures (as described
above) and/or by virtue of their capacity to invade the surrounding
brain substance (as can occur with Astrocytomas and Ependymomas).
Metastatic Tumors
While quite rare, metastatic malignancies can affect this region
producing symptoms consequent to compression, as well as invasion.
Nonneoplastic Mass Lesions (Pineal Cysts, Arachnoid Cysts,
Cysticercus Cysts, Vein of Galen Malformation)
All of these pathological entities produce symptoms by compressing
surrounding anatomical structures. All are amenable to surgical
management.
The surgical management of Pineal & Pineal Region Tumors lagged well
behind surgical treatment of other brain problems, because of the
central location within the cranial cavity and the vulnerability
of the many vital brain centers in this location. For decades the
Pineal Region was considered to be "No Man's Land". One
of the surgeons who founded Neurosurgical Consultants was
among the first to successfully remove various types of tumors and
pathological structures in the Pineal Region. Dr. Martin Lazar
first reported the resection of Third Ventricular Ependymoma,
Pineal Region Meningioma as well as Tumors of the Anterior
Superior Cerebellum at the 1973 Annual Meeting of the American
Association of Neurological Surgeons titled: "To Galen and
Back: Surgical Excision of Pineal Region Tumors". At that
time, and in subsequent scientific presentation, he described a
microneurosurgical occipital transtentorial direct approach,
which was adapted from a concept introduced in an earlier
neurosurgical era by Poppen. Subsequent publications by Dr. Lazar
established this technique and the possibility for Neurosurgeons
to access this region successfully. Other Neurosurgical authors
have described their experiences with this and other surgical
approaches to this region.
For further information, please consult Direct Surgical
Management of Masses in the Region of the Vein of Galen.
Surgical Neurology 2:17-21, 1974. (Lazar, M.L., and Clark,
W.K.), Thrombosed Aneurysm of the Vein of Galen
(Six, E.G., Cowley, A.R., Kelly, D.L., and Laster, D.W.) Critique
and Comments, Neurosurgery 7:274-278, 1980. (Lazar, M.L.),
Pineal Region Meningioma: Report of Two cases and Literature
Review (Piatti, J.H. and Campbell, G.A.) Critique and
Comments, Neurosurgery 2:369-375, 1983. (Lazar, M.L.)
Prior to the introduction of microneurosurgical techniques and
limited access procedures, the treatment of Pineal Region Tumors
was largely confined to shunting of the ventricles to control the
hydrocephalus followed by radiation therapy. Mortality rates were
high.
Modern treatment of Pineal Region Tumors involves:
- Control of hydrocephalus
- Complete surgical removal of benign encapsulated tumors of
the Pineal Region
- Histological identification of nonresectable followed by
radiation and chemotherapy
Stereotactic biopsy (which has low morbidity and mortality rates
and gives satisfactory biopsy samples) of Pineal Region Tumors is
an alternative to direct surgical exposure and may be preferable
for certain types of tumors that are clearly not surgically resectable
and can be treated with other techniques. Endoscopic surgery can
also be accomplished and offers some advantage over stereotactic
biopsies, in that the surgeon can actually inspect the lesion and
surrounding tissue prior to taking samples. Stereotactic Image
Guided Endoscopic Techniques are now available in some centers.
More than 70% of Pineal Region Tumors are responsive to radiation
therapy within 3 to 6 months of treatment. Germinomas are
particularly responsive to radio-therapy. In many instances,
ventricular shunting followed by radiation therapy, is the
treatment of choice.
Chemotherapy treatment is effective for some Pineal Region Tumors
with the choice of chemotherapeutic agents being dependent upon
the type of tumor.
Return to Top of Page
This page last edited on 2/20
|